238 related articles for article (PubMed ID: 19945021)
1. The pathophysiology of pituitary adenomas.
Dworakowska D; Grossman AB
Best Pract Res Clin Endocrinol Metab; 2009 Oct; 23(5):525-41. PubMed ID: 19945021
[TBL] [Abstract][Full Text] [Related]
2. The molecular pathogenesis of corticotroph tumours.
Dworakowska D; Grossman AB
Eur J Clin Invest; 2012 Jun; 42(6):665-76. PubMed ID: 22098190
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility to pituitary neoplasia related to MEN-1, CDKN1B and AIP mutations: an update.
Karhu A; Aaltonen LA
Hum Mol Genet; 2007 Apr; 16 Spec No 1():R73-9. PubMed ID: 17613551
[TBL] [Abstract][Full Text] [Related]
4. Molecular genetics of the cAMP-dependent protein kinase pathway and of sporadic pituitary tumorigenesis.
Boikos SA; Stratakis CA
Hum Mol Genet; 2007 Apr; 16 Spec No 1():R80-7. PubMed ID: 17613552
[TBL] [Abstract][Full Text] [Related]
5. Pituitary adenoma pathogenesis: an update.
Rostad S
Curr Opin Endocrinol Diabetes Obes; 2012 Aug; 19(4):322-7. PubMed ID: 22617628
[TBL] [Abstract][Full Text] [Related]
6. The genetics of pituitary adenomas.
Vandeva S; Jaffrain-Rea ML; Daly AF; Tichomirowa M; Zacharieva S; Beckers A
Best Pract Res Clin Endocrinol Metab; 2010 Jun; 24(3):461-76. PubMed ID: 20833337
[TBL] [Abstract][Full Text] [Related]
7. Update on familial pituitary tumors: from multiple endocrine neoplasia type 1 to familial isolated pituitary adenoma.
Daly AF; Tichomirowa MA; Beckers A
Horm Res; 2009 Jan; 71 Suppl 1():105-11. PubMed ID: 19153518
[TBL] [Abstract][Full Text] [Related]
8. The molecular biology of pituitary tumors: a personal perspective.
Grossman AB
Pituitary; 2009; 12(3):265-70. PubMed ID: 19058014
[TBL] [Abstract][Full Text] [Related]
9. Familial pituitary adenomas.
Vandeva S; Vasilev V; Vroonen L; Naves L; Jaffrain-Rea ML; Daly AF; Zacharieva S; Beckers A
Ann Endocrinol (Paris); 2010 Dec; 71(6):479-85. PubMed ID: 20961530
[TBL] [Abstract][Full Text] [Related]
10. Hormonal signaling and pituitary adenomas.
Spada A; Lania A; Mantovani G
Neuroendocrinology; 2007; 85(2):101-9. PubMed ID: 17337884
[TBL] [Abstract][Full Text] [Related]
11. Mutations of the MEN1 tumor suppressor gene in pituitary tumors.
Zhuang Z; Ezzat SZ; Vortmeyer AO; Weil R; Oldfield EH; Park WS; Pack S; Huang S; Agarwal SK; Guru SC; Manickam P; Debelenko LV; Kester MB; Olufemi SE; Heppner C; Crabtree JS; Burns AL; Spiegel AM; Marx SJ; Chandrasekharappa SC; Collins FS; Emmert-Buck MR; Liotta LA; Asa SL; Lubensky IA
Cancer Res; 1997 Dec; 57(24):5446-51. PubMed ID: 9407947
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the MEN1 gene in sporadic pituitary adenomas.
Schmidt MC; Henke RT; Stangl AP; Meyer-Puttlitz B; Stoffel-Wagner B; Schramm J; von Deimling A
J Pathol; 1999 Jun; 188(2):168-73. PubMed ID: 10398160
[TBL] [Abstract][Full Text] [Related]
13. Novel Genetic Causes of Pituitary Adenomas.
Caimari F; Korbonits M
Clin Cancer Res; 2016 Oct; 22(20):5030-5042. PubMed ID: 27742789
[TBL] [Abstract][Full Text] [Related]
14. Genetic factors in the development of pituitary adenomas.
Vandeva S; Tichomirowa MA; Zacharieva S; Daly AF; Beckers A
Endocr Dev; 2010; 17():121-133. PubMed ID: 19955762
[TBL] [Abstract][Full Text] [Related]
15. Clinical and Molecular Update on Genetic Causes of Pituitary Adenomas.
Vasilev V; Daly AF; Zacharieva S; Beckers A
Horm Metab Res; 2020 Aug; 52(8):553-561. PubMed ID: 32299111
[TBL] [Abstract][Full Text] [Related]
16. Targeting Raf/MEK/ERK pathway in pituitary adenomas.
Suojun Z; Feng W; Dongsheng G; Ting L
Eur J Cancer; 2012 Feb; 48(3):389-95. PubMed ID: 22119203
[TBL] [Abstract][Full Text] [Related]
17. No evidence of somatic aryl hydrocarbon receptor interacting protein mutations in sporadic endocrine neoplasia.
Raitila A; Georgitsi M; Karhu A; Tuppurainen K; Mäkinen MJ; Birkenkamp-Demtröder K; Salmenkivi K; Orntoft TF; Arola J; Launonen V; Vahteristo P; Aaltonen LA
Endocr Relat Cancer; 2007 Sep; 14(3):901-6. PubMed ID: 17914118
[TBL] [Abstract][Full Text] [Related]
18. The epidemiology and genetics of pituitary adenomas.
Daly AF; Tichomirowa MA; Beckers A
Best Pract Res Clin Endocrinol Metab; 2009 Oct; 23(5):543-54. PubMed ID: 19945022
[TBL] [Abstract][Full Text] [Related]
19. Akting and cycling: a tale of the pituitary.
Grossman AB; Korbonits M
Horm Res; 2004; 62 Suppl 3():117-23. PubMed ID: 15539812
[TBL] [Abstract][Full Text] [Related]
20. Activation of RAF/MEK/ERK and PI3K/AKT/mTOR pathways in pituitary adenomas and their effects on downstream effectors.
Dworakowska D; Wlodek E; Leontiou CA; Igreja S; Cakir M; Teng M; Prodromou N; Góth MI; Grozinsky-Glasberg S; Gueorguiev M; Kola B; Korbonits M; Grossman AB
Endocr Relat Cancer; 2009 Dec; 16(4):1329-38. PubMed ID: 19620247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
